Patents by Inventor Daniel Alam

Daniel Alam has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11956855
    Abstract: A system enables a home operator to establish an automated monitoring process which identifies outage events on competitor wireless networks (e.g., peer operators) operating in the same geographies as home operator. The home operator then is able to selectively offer, in near real-time, to open roaming to the peer operator, or implement roaming automatically based on predefined and mutually agreed upon rule sets. The monitoring process may observe non-customer attach request volumes in order to identify outage events on competitor wireless networks.
    Type: Grant
    Filed: October 12, 2021
    Date of Patent: April 9, 2024
    Assignees: AT&T Intellectual Property I, L.P., AT&T Mobility II LLC
    Inventors: Robert S. Klein, Mohammed Yousuffi, Nathan Stowell, Senthil Raj Dhandapani, Daniel Powell, Iftekhar Alam, Slawomir Stawiarski, William Turczyn, Ngwane Maina
  • Publication number: 20240083292
    Abstract: Electric vehicle charging systems and methods are provided, which include an energy storage unit and a docking station sized to accommodate the energy storage unit within the docking station in a docked position. The docking station includes an energy storage docking receptacle to operatively couple the energy storage unit to the docking station in the docked position. The electric vehicle charging system facilitates charging an electric vehicle battery.
    Type: Application
    Filed: September 13, 2023
    Publication date: March 14, 2024
    Applicant: SparkCharge, Inc.
    Inventors: Rifat Alam SIDDIQUE, Daniel JANOWIEC
  • Publication number: 20240083293
    Abstract: Modular electric vehicle charging systems and methods are provided which include a swappable energy storage unit and a charger unit. The swappable energy storage unit and the charger unit are operatively coupled via a detachable cable assembly, and at least one control is provided to control charging of an electric vehicle battery by the modular electric vehicle charging system.
    Type: Application
    Filed: September 13, 2023
    Publication date: March 14, 2024
    Applicant: SparkCharge, Inc.
    Inventors: Rifat Alam SIDDIQUE, Daniel JANOWIEC
  • Patent number: 8207262
    Abstract: A dihydroxyphenyl cross-linked macromolecular network is provided that is useful in artificial tissue and tissue engineering applications, particularly to provide a synthetic macromolecular network for a wide variety of tissue types. In particular, artificial or synthetic cartilage, vocal cord material, vitreous material, soft tissue material and mitral valve material are described. In an embodiment, the network is composed of tyramine-substituted and cross-linked hyaluronan molecules, wherein cross-linking is achieved via peroxidase-mediated dityramine-linkages that can be performed in vivo. The dityramine bonds provide a stable, coherent hyaluronan-based hydrogel with desired physical properties.
    Type: Grant
    Filed: September 15, 2008
    Date of Patent: June 26, 2012
    Assignee: The Cleveland Clinic Foundation
    Inventors: Anthony Calabro, Lee Akst, Daniel Alam, James Chan, Aniq B. Darr, Kiyotaka Fukamachi, Richard A. Gross, David Haynes, Keiji Kamohara, Daniel P. Knott, Hilel Lewis, Alex Melamud, Anthony Miniaci, Marshall Strome
  • Publication number: 20090143766
    Abstract: A dihydroxyphenyl cross-linked macromolecular network is provided that is useful in artificial tissue and tissue engineering applications, particularly to provide a synthetic macromolecular network for a wide variety of tissue types. In particular, artificial or synthetic cartilage, vocal cord material, vitreous material, soft tissue material and mitral valve material are described. In an embodiment, the network is composed of tyramine-substituted and cross-linked hyaluronan molecules, wherein cross-linking is achieved via peroxidase-mediated dityramine-linkages that can be performed in vivo. The dityramine bonds provide a stable, coherent hyaluronan-based hydrogel with desired physical properties.
    Type: Application
    Filed: January 29, 2009
    Publication date: June 4, 2009
    Applicant: The Cleveland Clinic Foundation
    Inventors: Anthony Calabro, Lee Akst, Daniel Alam, James Chan, Aniq B. Darr, Kiyotaka Fukumachi, Richard A. Gross, David Haynes, Keiji Kamohara, Daniel P. Knott, Hilel Lewis, Alex Melamud, Anthony Miniaci, Marshall Strome
  • Publication number: 20090142309
    Abstract: A dihydroxyphenyl cross-linked macromolecular network is provided that is useful in artificial tissue and tissue engineering applications, particularly to provide a synthetic macromolecular network for a wide variety of tissue types. In particular, artificial or synthetic cartilage, vocal cord material, vitreous material, soft tissue material and mitral valve material are described. In an embodiment, the network is composed of tyramine-substituted and cross-linked hyaluronan molecules, wherein cross-linking is achieved via peroxidase-mediated dityramine-linkages that can be performed in vivo. The dityramine bonds provide a stable, coherent hyaluronan-based hydrogel with desired physical properties.
    Type: Application
    Filed: January 29, 2009
    Publication date: June 4, 2009
    Applicant: The Cleveland Clinic Foundation
    Inventors: Anthony Calabro, Lee Akst, Daniel Alam, James Chan, Aniq B. Darr, Kiyotaka Fukamachi, Richard A. Gross, David Haynes, Keiji Kamohara, Daniel P. Knott, Hilel Lewis, Alex Melamud, Anthony Miniaci, Marshall Strome
  • Publication number: 20090042294
    Abstract: A dihydroxyphenyl cross-linked macromolecular network is provided that is useful in artificial tissue and tissue engineering applications, particularly to provide a synthetic macromolecular network for a wide variety of tissue types. In particular, artificial or synthetic cartilage, vocal cord material, vitreous material, soft tissue material and mitral valve material are described. In an embodiment, the network is composed of tyramine-substituted and cross-linked hyaluronan molecules, wherein cross-linking is achieved via peroxidase-mediated dityramine-linkages that can be performed in vivo. The dityramine bonds provide a stable, coherent hyaluronan-based hydrogel with desired physical properties.
    Type: Application
    Filed: September 15, 2008
    Publication date: February 12, 2009
    Applicant: The Cleveland Clinic Foundation
    Inventors: Anthony Calabro, Lee Akst, Daniel Alam, James Chan, Aniq B. Darr, Kiyotaka Fukamachi, Richard A. Gross, David Haynes, Keiji Kamohara, Daniel P. Knott, Hilel Lewis, Alex Melamud, Anthony Miniaci, Marshall Strome
  • Patent number: 7465766
    Abstract: A dihydroxyphenyl cross-linked macromolecular network is provided that is useful in artificial tissue and tissue engineering applications, particularly to provide a synthetic, implantable tissue matrix material for a wide variety of tissue types. In particular, artificial or synthetic cartilage, vocal cord material, vitreous material, soft tissue material and mitral valve material are described. In an embodiment, the network is composed of tyramine-substituted and cross-linked hyaluronan molecules, wherein cross-linking is achieved via peroxidase-mediated dityramine-linkages that can be performed in vivo. The dityramine bonds provide a stable, coherent hyaluronan-based hydrogel with desired physical properties.
    Type: Grant
    Filed: July 7, 2005
    Date of Patent: December 16, 2008
    Assignee: The Cleveland Clinic Foundation
    Inventors: Anthony Calabro, Lee Akst, Daniel Alam, James Chan, Aniq B. Darr, Kiyotaka Fukamachi, Richard A. Gross, David Haynes, Keiji Kamohara, Daniel P. Knott, Hilel Lewis, Alex Melamud, Anthony Miniaci, Marshall Strome
  • Publication number: 20060084759
    Abstract: A dihydroxyphenyl cross-linked macromolecular network is provided that is useful in artificial tissue and tissue engineering applications, particularly to provide a synthetic, implantable tissue matrix material for a wide variety of tissue types. In particular, artificial or synthetic cartilage, vocal cord material, vitreous material, soft tissue material and mitral valve material are described. In an embodiment, the network is composed of tyramine-substituted and cross-linked hyaluronan molecules, wherein cross-linking is achieved via peroxidase-mediated dityramine-linkages that can be performed in vivo. The dityramine bonds provide a stable, coherent hyaluronan-based hydrogel with desired physical properties.
    Type: Application
    Filed: July 7, 2005
    Publication date: April 20, 2006
    Applicant: The Cleveland Clinic Foundation
    Inventors: Anthony Calabro, Lee Akst, Daniel Alam, James Chan, Aniq Darr, Kiyotaka Fukamachi, Richard Gross, David Haynes, Keiji Kamohara, Daniel Knott, Hilel Lewis, Alex Melamud, Anthony Miniaci, Marshall Strome